We are an independent, privately-owned Contract Development Manufacturing Organisation (CDMO). We specialise in the development of innovative new entities for biotech companies, globally. We create robust formulation development strategies tailored to the characteristics of each individual API.
We complement the drug discovery process with clearly set-out costs for specific stages, totally transparent from the preclinical stage, formulation, dosage form development and optimisation.Experienced formulation development and licensed for the clinical manufacture of live biotherapeutics products for digestive, urogenital and pulmonary delivery.
We complement the drug discovery process with clearly set-out costs for specific stages, totally transparent from the preclinical stage, formulation, dosage form development and optimisation.Experienced formulation development and licensed for the clinical manufacture of live biotherapeutics products for digestive, urogenital and pulmonary delivery.
Services
Established in 2002 by Professor Mike Rubinstein, Quay Pharma is an independent, privately-owned company with the scientific expertise to respond flexibly to each new challenge, and give every project the best possible chance of a successful clinical trial.
By far, our most important asset is an exceptional depth of knowledge and experience that enables us to design novel and effective drug delivery systems built on a fundamental scientific and technical understanding of our clients' requirements.Quay Pharma offer every client a bespoke approach matched precisely to their needs and circumstances.
By far, our most important asset is an exceptional depth of knowledge and experience that enables us to design novel and effective drug delivery systems built on a fundamental scientific and technical understanding of our clients' requirements.Quay Pharma offer every client a bespoke approach matched precisely to their needs and circumstances.
We continually develop pharmaceutical products with world-leading expertise that support safety, quality and commercial viability. We innovate and challenge ourselves to be the very best in our field. At Quay Pharma our job is not simply to find an effective method of drug delivery for each new product, it is to find the best and most effective method possible.
Quay Pharma are unique in both the academic standing of our scientists, and our drive to discover the most elegant and effective response, not the first or most obvious, to every challenge of drug delivery and dosage. Our senior commercial and technical team brings together an impressive breadth and depth of experience from academia, the pharmaceutical industry and contract service organisations.
We create robust formulation development strategies tailored to the characteristics of each individual API. Within Quay Pharma we can provide virtually all of the services required to bring drug products through the various stages of clinical development quickly and cost-effectively. Quay Pharma has the expertise to give each product the best possible chance of success by optimising its delivery mechanism.
We believe in direct communication, honest dialogue, and collaborative working. Confidentiality is absolutely assured in every aspect of our service, from your first enquiry onwards.
Our in-house scientific expertise enables us to approach every project from the most fundamental principles, thoroughly researching your drug and building a complete understanding of its mechanism and potential efficacy, and then providing a dosage design that will deliver the best possible results.We understand the importance of costs and timelines, and make sure that these factors are clearly set out and agreed at the outset.
Our in-house scientific expertise enables us to approach every project from the most fundamental principles, thoroughly researching your drug and building a complete understanding of its mechanism and potential efficacy, and then providing a dosage design that will deliver the best possible results.We understand the importance of costs and timelines, and make sure that these factors are clearly set out and agreed at the outset.
Reviews
Be the first to review Quay Pharmaceuticals.
Write a Review
